This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Ono Pharmaceutical Co., Ltd., University of California. Active years: 2018-2025.
Company Filing History:
5 out of 575 
1 out of 15,988 
Years Active: 2018-2025
Title: Tohru Kotani: Innovator in Medicinal Chemistry
Introduction
Tohru Kotani is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors involved in various diseases. With a total of 5 patents to his name, Kotani's work is recognized for its potential impact on medical treatments.
Latest Patents
Kotani's latest patents include a tricyclic spiro compound that serves as a medicinal agent for the prevention and/or treatment of diseases caused by EPreceptor activation. This innovative compound contains antagonistic activity against the EPreceptor, making it a valuable asset in the medical field. The compound is represented by a specific general formula, and it can exist in various forms, including salts, N-oxides, or solvates, as well as prodrugs. This versatility enhances its utility as a medicinal component.
Career Highlights
Throughout his career, Tohru Kotani has worked with notable organizations, including Ono Pharmaceutical Co., Ltd. and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Kotani's coworkers include Masaki Asada and Kousuke Tani. Their collaborative efforts have further advanced the research and development of innovative medicinal compounds.
Conclusion
Tohru Kotani's contributions to medicinal chemistry highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for various diseases.